MENU

State

Friday, May 03, 2024

State gets $1.7 million in diabetes drug settlement

November 17, 2012 11:01 pm • Last Updated: October 31, 2014 9:31 am

Hartford - Connecticut is getting nearly $1.7 million to settle claims that British drug maker GlaxoSmithKline LLC deceptively promoted the diabetes drug Avandia. The payment is part of a $90 million settlement between GlaxoSmithKline and attorneys general from 38 different states.

Attorneys general say GlaxoSmithKline misrepresented Avandia's cardiovascular risks and safety profile. The agreement requires the company to reform its marketing practices.

GlaxoSmithKline doesn't admit any wrongdoing.

- Associated Press

Comment threads are monitored for 48 hours after publication and then closed.

STORIES THAT MAY INTEREST YOU

The lion is back at Mohegan Park in Norwich

Norwich ― The zoo is long gone from Mohegan Park, but a beloved lion has returned. A bright yellow lion drinking fountain that long adorned the entrance to the former zoo has been refurbished with new...

Hicks, ex-Trump adviser, recounts fear in 2016 over impact of 'Access Hollywood' tape

New York — Donald Trump’s 2016 campaign was seized with worry about the potential political damage from a tape that showed Trump bragging about grabbing women sexually without their permission, longti...

Striking deals to end campus protests, some colleges invite discussion of their investments

New York — Anti-war demonstrations ceased this week at a small number of U.S. universities after school leaders struck deals with pro-Palestinian protesters, fending off possible disruptions of final ...

Executive director who led Norwich Historical Society to prominence departs

Norwich― From walking tours to events and efforts to preserve historic buildings, the Norwich Historical Society has taken a prominent role in promoting Norwich history. Society leaders credit part-ti...